This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
healthcare: Archive
UnitedHealthcare Pressure Builds: Trouble Ahead for UNH's Q2 Earnings?
by Kaibalya Pravo Dey
UNH braces for a steep Q2 profit drop as soaring medical costs and DOJ scrutiny shake investor confidence.
UNHNegative Net Change HUMNegative Net Change MOHNegative Net Change
earnings-outlook earnings-preview healthcare hmo insurance insurance-premium medical
UnitedHealth on Thin Ice Before Q2 Earnings: Should Investors Exit?
by Kaibalya Pravo Dey
UNH braces for a 27% earnings drop in Q2 as soaring medical costs, margin pressure and investor jitters weigh on performance.
UNHNegative Net Change HUMNegative Net Change MOHNegative Net Change
earnings-outlook earnings-preview healthcare hmo insurance insurance-premium medical
CVS Q2 Estimates Dip: Is the Stock Still a Buy Ahead of Q2 Earnings?
by Urmimala Biswas
Earnings estimates for CVS dip ahead of Q2 results, but turnaround efforts in Aetna and PBM strength may offset pressure.
UNHNegative Net Change CVSNegative Net Change HLFNegative Net Change
earnings-estimates-revisions earnings-outlook earnings-preview earnings-report earnings-streak earnings-surprise healthcare medical medical-devices retail
TEM Shares Surge on New AI Breakthrough: Should Investors Jump In?
by Urmimala Biswas
TEM stock rallies 7.3% after the FDA clears its second cardiology AI tool, witnessing a 48% surge in just three months.
AZNNegative Net Change IRTCNegative Net Change SOPHNegative Net Change TEMNegative Net Change
artificial-intelligence healthcare medical medical-devices
CVS Up on Medicare Advantage Strength: Is It a Buy Before Q2 Earnings?
by Urmimala Biswas
CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.
UNHNegative Net Change CINegative Net Change CVSNegative Net Change
healthcare medical retail smart-health
Smart Money Going in Senior Health: Key Stocks in Elderly Care
by Urmimala Biswas
RHHBY, NVO, EW and SYK are ramping up senior care innovation as aging populations reshape global healthcare demand.
ABTNegative Net Change RHHBYNegative Net Change NVONegative Net Change MDTNegative Net Change SYKNegative Net Change EWNegative Net Change
healthcare medical medical-devices pharmaceuticals
These Top 4 Women-Run Company Stocks Are Quietly Beating the Market
by Shrabana Mukherjee
These women-run company stocks offer high growth and stability.
ACNPositive Net Change MCKPositive Net Change ELNegative Net Change ADBEPositive Net Change CNCNegative Net Change BMBLNegative Net Change
healthcare internet medical medical-devices tech-stocks thematic
CVS vs. Amazon: Healthcare Battle Continues- Which Stock to Buy Now?
by Urmimala Biswas
CVS surges with a 56% YTD return and an integrated care model, as AMZN bets on tech and logistics to reshape healthcare.
AMZNPositive Net Change CVSNegative Net Change
healthcare medical retail smart-health
BTSG vs. OPCH: Which Home Infusion Stock is a Better Buy Now?
by Urmimala Biswas
BTSG surges with 33% infusion growth and stronger EPS gains, making it a more compelling pick than OPCH right now.
OPCHNegative Net Change PLTRPositive Net Change BTSGNegative Net Change
earnings-estimates-revisions earnings-outlook earnings-report healthcare hospitals medical smart-health
TEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now?
by Urmimala Biswas
GH gains ground with stronger guidance, improving margin and Reveal's breakout as TEM scales fast but stays unprofitable.
AZNNegative Net Change GHPositive Net Change TEMNegative Net Change
artificial-intelligence biotechnology cancer earnings-outlook healthcare medical